Skip to main content

Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020 - GlobeNewswire

Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020 - GlobeNewswire


Beyond Air Reports Financial Results for Fiscal Fourth Quarter and Year-End 2020 - GlobeNewswire

Posted: 22 Jun 2020 01:14 PM PDT

Reported positive clinical data for third bronchiolitis study using high concentration nitric oxide, achieving primary and key secondary endpointsEnrolled first patient in the U.S. COVID-19 study using the LungFitsystemAnnounced positive pre-clinical data validating high concentration nitric oxide as a potential treatment for ablating solid tumors and inducing an anti-tumor immune responsePMA for the LungFit™ PH to treat persistent pulmonary hypertension of the newborn (PPHN) expected to be submitted to the FDA in the second half of 2020LungFit

Comments

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org

What to Expect During Pulmonary Embolism Recovery - Healthline